Results 161 to 170 of about 14,367,683 (357)

Predicting and Comparing the Subjective Health Experience of Older Cancer Survivors and Non‐Cancer Survivors: A Modeling Approach

open access: yesAging and Cancer, EarlyView.
This study underscores the significant influence of frailty and vitality on the subjective health experience of older cancer survivors with acceptance and control emerging as salient mediators. These findings affirm the conceptual and empirical robustness of the model highlighting its potential utility in shaping future interventions for older cancer ...
Damien S. E. Broekharst   +4 more
wiley   +1 more source

Hybrid AI and semiconductor approaches for power quality improvement. [PDF]

open access: yesSci Rep
Chinthaginjala R   +5 more
europepmc   +1 more source

Overview of energy storage systems in distribution networks: Placement, sizing, operation, and power quality

open access: yesRenewable & Sustainable Energy Reviews, 2018
C. K. Das   +4 more
semanticscholar   +1 more source

Natural Products as Geroprotective Modulators in Diabetic Nephropathy: A Mechanistic Framework Integrating Aging Hallmarks and the AMPK–SIRT1–Nrf2 Axis

open access: yesAging and Cancer, EarlyView.
Natural products target the aging kidney in diabetic nephropathy by restoring the AMPK–SIRT1–Nrf2 axis, reducing oxidative stress, inflammation, fibrosis, and cellular senescence while enhancing mitochondrial biogenesis and antioxidant defenses.
Sherif Hamidu   +8 more
wiley   +1 more source

Robust Federated-Learning-Based Classifier for Smart Grid Power Quality Disturbances. [PDF]

open access: yesSensors (Basel)
Alsabaan M   +6 more
europepmc   +1 more source

Harmonic Mitigation using Hybrid Power Filter to Improve Power Quality

open access: bronze, 2023
Mrs. Prajkta R Gangurde   +3 more
openalex   +2 more sources

Prognostic Impact of European LeukemiaNet Genetic Risk Stratification System in Adult Patients With Acute Myeloid Leukemia

open access: yesAging and Cancer, EarlyView.
This study aimed to evaluate the prognostic value of ELN2017 in predicting survival outcomes and to assess the impact of clinical and molecular factors such as age, FLT3 and NPM1 mutations, and allogeneic hematopoietic stem cell transplantation (allo‐HSCT).
Mobina Shrestha   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy